9-Hydrazinylacridine is an organic compound characterized by the presence of a hydrazine functional group attached to an acridine moiety. This compound typically exhibits properties associated with both aromatic and amine functionalities, which can influence its reactivity and interactions. It is often studied for its potential applications in medicinal chemistry, particularly in the development of antitumor agents and other therapeutic compounds due to its ability to intercalate with DNA. The structure of 9-hydrazinylacridine allows for various chemical modifications, which can enhance its biological activity or alter its solubility and stability. Additionally, it may exhibit fluorescence properties, making it useful in biological imaging applications. As with many hydrazine derivatives, safety precautions are necessary when handling this compound, as hydrazines can be toxic and potentially carcinogenic. Overall, 9-hydrazinylacridine represents a significant interest in both synthetic and medicinal chemistry fields, warranting further investigation into its properties and applications.

9-Hydrazinylacridine

3407-93-0: 9-Acridinylhydrazine, 9-Hydrazinoacridine, Acridine, 9-Hydrazinyl-, Acridine, 9-hydrazino-, NSC 138673, NSC 14977, 9-Hydrazinylacridine

9-Hydrazinoacridine

9-Hydrazinoacridine is an aromatic compound that has been identified as a potential drug candidate for the treatment of tropical diseases such as schistosomiasis and lymphocytic leukemia. The computational method used to analyze 9-hydrazinoacridine's chemical structure suggested that it has a biological function similar to that of histamine, in that it activates the H1 receptor. The presence of hydrazine on the molecule may allow for better absorption through the skin, which would be beneficial for topical treatments. This compound is also a potential drug candidate because it is non-toxic to human cells and non-mutagenic, meaning it does not cause mutations in DNA. 9-Hydrazinoacridine absorbs ultraviolet light strongly, which could make it useful as a photosensitizer for photodynamic therapy (PDT) treatments.

CAS 3407-93-0: 9-Hydrazinylacridine

9-Hydrazinoacridine

Ref: 54-OR7096

9-Hydrazinoacridine

Ref: 3D-FH132996